An Intermediate Size Expanded Access Protocol of AMX0035 for ALS

Summary

The Expanded Access Program will provide access and assess the safety of AMX0035 for the treatment of people living with ALS.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications